Safety Data Sheets
The following are application specific references on the use of LACTEL Absorbable Polymers.
Polymer Specific References
PLA Poly(DL-Lactide) and Poly(L-lactide)
Novel Poly (L-lactide) PLLA/SWNTs Nanocomposites for Biomedical Applications: Material Characterization and Biocompatibility Evaluation.
Armentano I, Marinucci L, et al.
Journal of Biomaterials Science, Polymer Edition, 22 2011; 4(6):541-556
Controlling the morphology of electrospray-generated PLGA microparticles for drug delivery.
Almeria B, Deng W et al.
Journal of Colloid and Interface Science 2010; 343(1):125-133
Antithrombogenic Modification of Small-Diameter Microfibrous Vascular Grafts. Arteriosclerosis, thrombosis, and vascular biology
Hashi CK, Derugin N, et al.
Arteriosclerosis, thrombosis, and vascular biology
Porous PLGA microspheres effectively loaded with BSA protein by electrospraying combined with phase separation in liquid nitrogen.
Liu G, Miao X, et al.
Journal of Biomimetics, Biomaterials, and Tissue Engineering 2010; 6:1-18
Development of L-PLA based Intrascleral Implant for Sustained Intraocular Delivery of Dexamethasone Sodium Phosphate.
Zaman N, Talukder MMU, et al.
Stamford Journal of Pharmaceutical Sciences 2010; 2(1):56-60
Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules.
Carpenedo RL, Bratt-Leal AM, et al.
Biomaterials 2009; 30(13):2507-2515
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.
Demento SL, Eisenbarth SC et al.
Vaccine 2009; 27(23):3013-3021
Release Kinetics of Polymer-Bound Bone Morphogenetic Protein-2 and Its Effects on the Osteogenic Expression of MC3T3-E1 Osteoprecursor Cells.
Gharibjanian NA, Chua WC, et al.
Plastic and Reconstructive Surgery 2009; 123(4):1169-1177
The effect of porosity and mechanical property of a synthetic polymer scaffold on repair of osteochondral defects.
Ikeda R, Fujioka H, et al.
International Orthopaedics 2009; 33(3):821-828
Preparation of macromolecule-containing dry powders for pulmonary delivery.
Kraft KS, Grant M. et al.
Methods in molecular biology (Clifton, NJ) 2009; 480:165
The reliable targeting of specific drug release profiles by integrating arrays of different albumin-encapsulated microsphere types.
Lee W, Wiseman ME, et al.
Biomaterials 2009; 30(34):6648-6654
The stress relaxation characteristics of composite matrices etched to produce nanoscale surface features.
Mirani RD, Pratt J, et al.
Biomaterials 2009; 30(5):703-710
Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury.
Reddy MK, Labhasetwar V, et al.
The FASEB Journal 2009; 23(5):1384-1395
Sustained delivery of endostatin improves the efficacy of therapy in Lewis lung cancer model.
Wu J, Ding D, et al.
Journal of Controlled Release 2009; 134(2):91-97
A study of drug release from homogeneous PLGA microstructures.
Acharya G, Shin CS, et al.
Journal of Controlled Release 2010; 146(2):201-206
Endothelial cell scaffolds generated by 3D direct writing of biodegradable polymer microfibers.
Berry SM, Warren SP, et al.
Biomaterials 2010; 32(7):1872-1879
Biosurface engineering through ink jet printing.
Khan MS, Fon D, et al.
Colloids and Surfaces B: Biointerfaces 2010; 75(2):441-447
Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration.
Soderquist RG, Sloane EM et al.
Pharmaceutical Research 2010; 27(5):841-854
A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
Acharya AP, Clare-Salzler MJ, et al.
Biomaterials 2009; 30(25):4168-4177
Local Delivery of Poly Lactic-co-glycolic Acid Microspheres Containing Imatinib Mesylate Inhibits Intracranial Xenograft Glioma Growth.
Benny O, Menon LG, et al.
Clinical Cancer Research 2009; 15(4):1222
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.
Cartiera MS, Johnson KM, et al.
Biomaterials 2009; 30(14):2790-2798
Intratumoral Delivery of beta-Lapachone via Polymer Implants for Prostate Cancer Therapy.
Dong Y, Chin SF, et al.
Clinical Cancer Research 2009; 15(1):131-139
Formulation/Preparation of functionalized nanoparticles for in vivo targeted drug delivery.
Gu F, Langer R, et al.
Methods in molecular biology (Clifton, NJ) 2009; 544(Chapter 37):589-598
BSA-FITC-loaded microcapsules for in vivo delivery.
Kim BS, Oh JM, et al.
Biomaterials 2009; 30(5):902-909
Polypyrrole-coated electrospun PLGA nanofibers for neural tissue applications.
Lee JY, Bashur CA, et al.
Biomaterials 2009; 30(26):4325-4335
The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora.
Li B, Yoshii T, et al.
Biomaterials 2009; 30(35):6768-6779
Tissue-engineered arterial grafts: long-term results after implantation in a small animal model.
Mirensky TL, Nelson GN, et al.
Journal of Pediatric Surgery 2009; 44(6):1127-1133
The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction.
Tillman BW, Yazdani SK, et al.
Biomaterials 2009; 30(4):583-588
Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y, Bajaj N, et al.
Biomaterials 2009; 30(10):1947-1953
The influence of electrospun aligned poly (e-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes.
Choi JS, Lee SJ, et al.
Biomaterials 2008; 29:2899-2906
Transesterification and End Group Chemistry in Acid Terminated Biodegradable Polymers
Branham, Keith E.; Mukherjee, R.; Hall, D.; and Gibson, J. Presented at the 34th Annual Meeting of the Controlled Release Society. July 9, 2007.
The effect of PEG end groups on the degradation of a 75/25 poly(DL-lactide-co-glycolide)
Middleton, John and Yarbrough, Julie C.
Presented at the 23rd Annual Meeting of the Society for Biomaterials Meeting. April 28 - May 2, 1999. Providence, Rhode Island..